Rokos Capital Management LLP Elanco Animal Health Inc Transaction History

Rokos Capital Management LLP

  • $5.96 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$9.81 - $12.62 $8.18 Million - $10.5 Million
-833,787 Reduced 13.52%
5,331,405 $59.9 Million
Q1 2023

May 15, 2023
BUY
$8.79 - $14.58 $18.9 Million - $31.3 Million
2,145,652 Added 53.38%
6,165,192 $58 Million
Q4 2022

Feb 14, 2023
BUY
$11.49 - $13.65 $39.9 Million - $47.4 Million
3,474,101 Added 636.94%
4,019,540 $49.1 Million
Q1 2022

May 16, 2022
BUY
$24.65 - $29.0 $13.4 Million - $15.8 Million
545,439 New
545,439 $14.7 Million

Others Institutions Holding ELAN

# of Institutions
438
Shares Held
473M
Call Options Held
4.62M
Put Options Held
753K
View Full List

About Elanco Animal Health Inc

ELAN Quotes by TradingView
  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Rokos Capital Management LLP Portfolio

Follow Rokos Capital Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rokos Capital Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Rokos Capital Management LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email